Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The Spectral / Ohtani

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Dec 10, 2023 8:22pm

194 Views

Post# 35777185

RE:RE:RE:The Spectral / Ohtani

I can't argue with any of that.

They need some sizzle.

I've been adding some Baxter on the pullback to the low 30's. All kidney related companies suffered on the "Ozempic miracle" - way overdone IMO

If the spin-off is done right ( and timed right) it should add value to existing Baxter SHers ... especially if there is some added sizzle ( like PMX?)

PMX could add $1-$2 B to their existing $4B (?) in a few short years. That's 50% growth... something that the market could get behind.

MM

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment